CPIX: Cumberland Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 59.78
Enterprise Value ($M) 61.89
Book Value ($M) 22.55
Book Value / Share 1.61
Price / Book 2.65
NCAV ($M) -16.59
NCAV / Share -1.19
Price / NCAV -3.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.08
Return on Equity (ROE) -0.24

Liquidity (mrq)
Quick Ratio 1.03
Current Ratio 1.15

Balance Sheet (mrq) ($M)
Current Assets 36.45
Assets 75.58
Liabilities 53.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 37.87
Operating Income -6.43
Net Income -6.48
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -0.61
Cash from Investing 0.06
Cash from Financing 0.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G Kazimi A J 40.80 -0.89
02-11 13G Integrated Core Strategies (us) Llc 8.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-07 10-K ____________________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 2,571 22,939 11.21
2025-04-02 1,791 13,517 13.25
2025-04-01 5,247 31,656 16.58
2025-03-31 1,132 45,064 2.51

(click for more detail)

Similar Companies
CGON – CG Oncology, Inc. COGT – Cogent Biosciences, Inc.
COLL – Collegium Pharmaceutical, Inc. CRBU – Caribou Biosciences, Inc.
CRGX – CARGO Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io